Eloxx Pharmaceuticals, Inc.
ELOX
Revenue
0.00
▼-200.00k▼-100.00%
12 Months ChangeAssets
6.04M
▲49.00k▲0.8176%
3 Months ChangeLiabilities
26.09M
▲1.50M▲6.10%
3 Months ChangeFree Cash Flow
-6.81M
▲2.69M▲28.29%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-17
Form 8-K
ID: 0001104659-24-109521
2024-07-16
Form 8-K
ID: 0001104659-24-080251
2024-03-29
Form 8-K
ID: 0001104659-24-041148
2024-03-14
Form 8-K
ID: 0001104659-24-034529
2024-01-09
Form 8-K
ID: 0001104659-24-002631
2023-12-28
Form 8-K
ID: 0001104659-23-130052
2023-12-15
Form 8-K
ID: 0001104659-23-126400
2023-11-13
Form 8-K
ID: 0001104659-23-117308
2023-11-13
Form 10-Q
ID: 0000950170-23-062940
2023-10-16
Form 8-K
ID: 0001104659-23-109423